Additional Information Taliglucerase Alfa [Elelyso] is approved for funding under the Rare Disease Fund
INTRAVENOUS Select a brand starting with the letter: E ELELYSO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200 UNITS/ VIAL [SIN16770P]